Rare
lephants
Screener
Toggle theme
MoonLake Immunotherapeutics
MLTX
·
Healthcare, Drug Manufacturers - General, Switzerland
Analysis
Financial Statements
Profitability
Balance Sheet
Cash Flow
Price Ratios
Share-Based Metrics
Valuation
Equity & Debt
Assets & Liabilities
Asset & Liabilities Breakdown
Balance Sheet
›
Equity & Debt
Annual
Quarterly
Compare
←
5Y
10Y
MAX
→
Equity & Debt
Chart
Table
Long Term Debt
Share Holder Equity
Cash on Hand
Fiscal Year
Long Term Debt
Share Holder Equity
Cash on Hand
FY2025
$74.1M
$304.5M
$334.5M
Download CSV
